Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to -$103.6 million.
- Benitec Biopharma's Enterprise Value fell 79717692.31% to -$103.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$103.6 million, marking a year-over-year change of. This contributed to the annual value of -$50.9 million for FY2024, which is 194534.14% down from last year.
- Latest data reveals that Benitec Biopharma reported Enterprise Value of -$103.6 million as of Q1 2025, which was down 79717692.31% from -$78.3 million recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Enterprise Value ranged from a high of -$13000.0 in Q1 2024 and a low of -$103.6 million during Q1 2025
- For the 5-year period, Benitec Biopharma's Enterprise Value averaged around -$26.8 million, with its median value being -$15.7 million (2021).
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 9980.34% in 2024, then tumbled by 79717692.31% in 2025.
- Over the past 5 years, Benitec Biopharma's Enterprise Value (Quarter) stood at -$12.3 million in 2021, then grew by 14.42% to -$10.6 million in 2022, then crashed by 93.48% to -$20.4 million in 2023, then tumbled by 283.78% to -$78.3 million in 2024, then crashed by 32.29% to -$103.6 million in 2025.
- Its last three reported values are -$103.6 million in Q1 2025, -$78.3 million for Q4 2024, and -$67.9 million during Q3 2024.